CGP

Space Engine Systems Successful in UK MoD Hypersonic Technology Challenge

Retrieved on: 
onsdag, maj 29, 2024

Space Engine Systems (SES), through its UK operations based out of Spaceport Cornwall (SES Ltd), has applied its aerospace technology expertise to a £1 Billion GBP ($1.27 Billion USD) challenge issued by the UK MoD linked to Hypersonic Technologies and was very recently notified that it had secured a place in the Hypersonic Technology and Capability Development Framework (HTCDF).

Key Points: 
  • Space Engine Systems (SES), through its UK operations based out of Spaceport Cornwall (SES Ltd), has applied its aerospace technology expertise to a £1 Billion GBP ($1.27 Billion USD) challenge issued by the UK MoD linked to Hypersonic Technologies and was very recently notified that it had secured a place in the Hypersonic Technology and Capability Development Framework (HTCDF).
  • This framework will enable the rapid development of advanced hypersonic missile capabilities, and related technology, over the next 7 years.
  • Pradeep Dass, President and CTO of Space Engine Systems noted, “We are looking forward to providing the UK MoD with innovative solutions to the complex challenge of hypersonic flight as well as being a part of the growth in the UK’s industrial base in this critical sector, which we can also leverage to support a sovereign UK space launch capability.
  • SES is also working closely with spaceport Cornwall, in the UK, by using a hangar at the spaceport for hypersonic flight testing.

Dr. Michael Donovan Joins Cellworks to Oversee Personalized Cancer Therapy Biosimulation in New CLIA-Certified Lab

Retrieved on: 
tisdag, maj 28, 2024

Prominent academic and biotech leader Dr. Michael Donovan, PhD MD, has joined Cellworks as Laboratory Director to spearhead computational biosimulation efforts for delivering Personalized Therapy Decision Support reports within the newly registered CLIA lab.

Key Points: 
  • Prominent academic and biotech leader Dr. Michael Donovan, PhD MD, has joined Cellworks as Laboratory Director to spearhead computational biosimulation efforts for delivering Personalized Therapy Decision Support reports within the newly registered CLIA lab.
  • This new facility signifies a major step forward in Cellworks’ aim to establish a novel transformation in Personalized Therapy Decision Support with an initial focus on delivering personalized therapy predictions for non-small cell lung cancer (NSCLC) patients.
  • The Cellworks Platform coupled with its in silico Computational Biology Model (CBM) utilizes genomic aberrations from a patient’s cancer tumor to reveal how the tumor will respond to therapies.
  • “We have an incredible opportunity to pioneer advancements in Personalized Therapy Biosimulation, starting with important breakthroughs for NSCLC patients.

Foundation Medicine Announces Details of Over 20 Presentations at the 2024 ASCO® Annual Meeting

Retrieved on: 
fredag, maj 24, 2024

Foundation Medicine, Inc ., today announced that 22 new pieces of research from its robust oncology diagnostics portfolio will be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting from May 31 to June 4 in Chicago.

Key Points: 
  • Foundation Medicine, Inc ., today announced that 22 new pieces of research from its robust oncology diagnostics portfolio will be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting from May 31 to June 4 in Chicago.
  • “We are also excited to demonstrate our new RNA sequencing capabilities and spotlight the expanding utility of ctDNA to inform treatment decision making through a simple blood sample.”
    The following is a complete list of Foundation Medicine abstracts that will be presented.
  • To access the abstracts being presented at ASCO, please visit ASCO.org/abstracts .
  • Follow Foundation Medicine on LinkedIn , X and Instagram for more updates from #ASCO24 and visit us in person at Booth #22031.

Guardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications

Retrieved on: 
tisdag, maj 21, 2024

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced certification for its Guardant360® CDx blood test under the European Union’s In Vitro Diagnostic Regulation (IVDR 2017/746).

Key Points: 
  • Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced certification for its Guardant360® CDx blood test under the European Union’s In Vitro Diagnostic Regulation (IVDR 2017/746).
  • The certification from TÜV SÜD Product Service is for tumor mutation profiling in patients with any solid cancerous tumor and for companion diagnostic indications to identify patients who may benefit from certain targeted therapies for advanced non-small cell lung cancer and breast cancer.
  • Under the previous EU regulatory framework (IVD Directive 98/79/EC), manufacturers were able to self-certify most of their molecular assays.
  • Guardant360 CDx is a next generation sequencing (NGS)-based assay that detects genomic alterations using circulating tumor DNA from blood.

United States Liquid Biopsy Market Report 2023 and 2024-2032 Featuring Thermo Fisher Scientific, Roche Diagnostics, Bio-Rad, Biocept, Biocartis, Myriad Genetics, Exact Sciences, NeoGenomics, Quest - ResearchAndMarkets.com

Retrieved on: 
tisdag, april 23, 2024

The "United States Liquid Biopsy Market Report by Cancer types, Products, Application, Biomarkers, Sample types, End-Users, and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States Liquid Biopsy Market Report by Cancer types, Products, Application, Biomarkers, Sample types, End-Users, and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offering.
  • The United States Liquid Biopsy Market value is foreseen to be around US$ 3.68 Billion by 2032.
  • These innovations enhance cancer detection and monitoring and propel the United States liquid biopsy market.
  • Breast cancer might stand out as a distinguished concern in the United States liquid biopsy market.

Creta, Thomas Vu, and Lloyds Investment Group Join Forces to Launch $1 Billion Fund, Accelerating Global Growth of Web3 Game Industry

Retrieved on: 
onsdag, februari 14, 2024

This collaboration underscores Creta's commitment to driving growth and innovation in the Web3 gaming market across the MENA region.

Key Points: 
  • This collaboration underscores Creta's commitment to driving growth and innovation in the Web3 gaming market across the MENA region.
  • It is envisioned that games will form integral components of the Creta Multiverse and Platform, presenting opportunities beyond the current $300 billion gaming industry.
  • Locus Chain, a pioneering blockchain protocol, renowned for its revolutionary approach in replacing central game servers, is joining the newly established fund.
  • By aligning with this initiative, Locus Chain reaffirms its commitment to driving innovation and fostering growth alongside Creta's partners.

AMERICAN GROUP PSYCHOTHERAPY ASSOCIATION ANNOUNCES LAUNCH OF EVIDENCE-BASED GROUP TREATMENT WEBSITE

Retrieved on: 
måndag, februari 12, 2024

NEW YORK, Feb. 12, 2024 /PRNewswire/ -- The American Group Psychotherapy Association announced the launch of an Evidence-Based Group Treatment Website at https://evidencebasedgrouptherapy.org/.

Key Points: 
  • Group Therapy Will be Key for Mental Health Treatment Access and New Website Will Serve as a Resource for Effective, Disorder Specific Group Treatments Supported by Evidence
    This website has been developed by an international team of renowned mental health professionals and supported by the American Psychological Association's Society of Group Psychology and Group Psychotherapy (Division 49), the American Group Psychotherapy Association (AGPA) with funding provided by the Group Foundation for Advancing Mental Health, and the German Health Ministry.
  • The use of group can address this issue, and this website can serve as a resource for treatment information and the basis of trainings to increase practitioner's comfort in providing group therapy.
  • Moreover, agencies who provide the highest percentage of group treatment in the US could extend their group treatment offerings by employing evidence-based protocols found on the website for the most common psychiatric disorders.
  • This website is a valuable resource in providing access to information on the most effective treatments for common mental health challenges."

Creta and Republic Form Strategic Partnership to Revolutionize Web3 and Metaverse Gaming

Retrieved on: 
onsdag, februari 7, 2024

Creta is a global Web3 metaverse gaming platform headquartered in the UAE with offices in Japan and Armenia.

Key Points: 
  • Creta is a global Web3 metaverse gaming platform headquartered in the UAE with offices in Japan and Armenia.
  • The Creta platform is developed by Diverse, a South Korean company specializing in metaverse games with a high-performance game engine and excellent graphics technology.
  • As a discerning force in the Web3 landscape, Republic is selective and strategic in their partnerships.
  • Republic is dedicated to fostering the Web3 ecosystem alongside Creta, and their partnership will involve advisory services, research-driven token economics, and investment facilitation.

Creta Partners with Lloyd Investment Group in Establishing a Fund to Enhance the Growth of Web3 Gaming Industry

Retrieved on: 
onsdag, februari 7, 2024

This collaboration involves the establishment of a new fund, currently valued at $1 billion, aimed at propelling the growth of the Web3 gaming industry across the MENA region.

Key Points: 
  • This collaboration involves the establishment of a new fund, currently valued at $1 billion, aimed at propelling the growth of the Web3 gaming industry across the MENA region.
  • The newly established fund will provide grants to emerging developers, enabling them to bring their game concepts to life.
  • With a cutting-edge gaming and entertainment platform, Creta aims to lead the next generation of game and metaverse content industries.
  • The new fund aims to expand the Creta metaverse by developing content and cultivating a pool of skilled developers.

Port Houston Community Grants Program Application Period Opens February 1

Retrieved on: 
tisdag, januari 16, 2024

Port Houston has announced the start of the application period for its Community Grants Program (CGP), beginning February 1.

Key Points: 
  • Port Houston has announced the start of the application period for its Community Grants Program (CGP), beginning February 1.
  • Port Houston is dedicated to supporting and helping improve the communities around the Houston Ship Channel.
  • Its Community Grants Program focuses on investing resources into meaningful projects and programs in our area.
  • Interested non-profits may access more information about Port Houston’s 2024 Community Grants Program, including dates, times, and links to the workshops, which can be found at https://porthouston.com/community/outreach/community-grants-program/